Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Feasibility of a 50% Dosing Interval Extension of Anti–IL-5 Biologics in Patients with Severe Asthma in Clinical Remission: A Real-World Validation Study
Saved in:
| Published in: | Journal of Asthma and Allergy |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|